NKILA and breast cancer: Recent studies have found that knockdown of lncRNA-NKILA in cytotoxic T lymphocytes regulates the sensitivity of T cells to activation-induced cell death by reducing the expression of NF-κB, thereby effectively inhibiting the growth of patient-derived xenografts from breast cancer in mice (123).